Vivet-Noguer Raquel, Tarin Malcy, Canbezdi Christine, Dayot Stephane, Silva Lisseth, Houy Alexandre, Martineau Sylvain, Mieulet Virginie, Gentric Géraldine, Loew Damarys, Lombard Bérangère, Nemati Fariba, Richon Sophie, Guyonnet Lea, Servois Vincent, Vagner Stephan, Stern Marc-Henri, Roman-Roman Sergio, Alsafadi Samar
Translational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.
INSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 75248 Paris, France.
Cancers (Basel). 2022 Apr 24;14(9):2113. doi: 10.3390/cancers14092113.
mutations are recurrent in cancer and result in aberrant splicing of a previously defined set of genes. Here, we investigated the fate of aberrant transcripts induced by mutant SF3B1 and the related functional consequences. We first demonstrate that mutant SF3B1 does not alter global nascent protein synthesis, suggesting target-dependent consequences. Polysome profiling revealed that 35% of aberrantly spliced transcripts are more translated than their corresponding canonically spliced transcripts. This mostly occurs in genes with enriched metabolic functions. Furthermore, LC-MS/MS analysis showed that mutant SF3B1 impacts the abundance of proteins involved in metabolism. Functional metabolic characterization revealed that mutant SF3B1 decreases mitochondrial respiration and promotes glycolysis to compensate for defective mitochondrial metabolism. Hence, mutant SF3B1 induces glycolysis dependency, which sensitizes cells to glycolysis inhibition. Overall, we provide evidence of the oncogenic involvement of mutant SF3B1 in uveal melanoma through a metabolic switch to glycolysis, revealing vulnerability to glycolysis inhibitors as a promising therapeutic strategy.
突变在癌症中经常出现,并导致一组先前定义的基因发生异常剪接。在此,我们研究了由突变型SF3B1诱导的异常转录本的命运及其相关的功能后果。我们首先证明,突变型SF3B1不会改变整体新生蛋白质合成,提示其具有靶标依赖性后果。多核糖体分析显示,35%的异常剪接转录本比其相应的经典剪接转录本翻译得更多。这主要发生在具有丰富代谢功能的基因中。此外,液相色谱-串联质谱分析表明,突变型SF3B1会影响参与代谢的蛋白质丰度。功能性代谢特征分析显示,突变型SF3B1会降低线粒体呼吸作用,并促进糖酵解以补偿有缺陷的线粒体代谢。因此,突变型SF3B1诱导糖酵解依赖性,使细胞对糖酵解抑制敏感。总体而言,我们提供了证据表明突变型SF3B1通过向糖酵解的代谢转变参与葡萄膜黑色素瘤的致癌过程,揭示了对糖酵解抑制剂的敏感性作为一种有前景的治疗策略。